Genmab | GEN - Capitalisation Boursière





Capitalisation Boursière Changement Date
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 209.65B 14.21B 2026-08
argenx SE USD 57.63B 13.25B 2026-06
AstraZeneca USD 178.16B 111.83B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Demant DKK 62.68B 5.89B 2026-08
Exelixis USD 15.27B 1.73B 2026-08
Fresenius Medical Care EUR 12.42B 1.87B 2026-08
Genmab DKK 126.96B 109.86B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GN Store Nord DKK 15.22B 890.39M 2026-03
GRIFOLS EUR 4.25B 1.16B 2026-08
Hikma Pharmaceutical USD 3.49B 1.14B 2026-08
Insmed USD 19.68B 3.43B 2026-08
Lakefront Biotherapeutics EUR 1.61B 115.98M 2026-08
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 62.37B 43.39B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12